Wei-Hong Tseng, founder and chairman of PharmaCore Biotech, introduces the specialized CDMO and its unique capacities to produce high value-added products. As a leading service provider in Taiwan, Tseng goes on to explain the company’s future strategy to not only continue its international expansion but also further enhance its innovative production capabilities while ultimately expanding into the production and marketing of their own advanced portfolio.
By using our innovative manufacturing platform combined with exclusive sterile powder filling technology, PharmaCore not only creates larger batches but also reduces the production time at the same time
